Coagulation Disorder
Conditions
Brief summary
The objective is to determine the initial reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge.
Detailed description
This is a single center prospective, observational study of a healthy adult population with normal coagulation function to determine the initial reference range intervals for the parameters reported by the Quantra System with the QStat Cartridge. The threshold for the Clot Stability to Lysis (CSL) parameter will be determined from the CSL reference range.
Interventions
DIAGNOSTIC_TESTQuantra System
Diagnostic device to monitor coagulation properties of a whole blood sample at the point-of-care.
Sponsors
HemoSonics LLC
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Subject is 18 years or older * Subject is willing to participate and has signed a consent form * Subject's laboratory coagulation test results at screening are within each test's normal reference range.
Exclusion criteria
* Subject is younger than 18 years * Subject has a history of a coagulation disorder * Subject is pregnant or lactating * Subject is currently taking medications known to alter coagulation * Subject has one or more laboratory coagulation test restuls outside of the normal reference range at screening * Subject had a blood transfusion or surgery within the last month * Drug abuse * Excessive alcohol consumption * Subject is unable to provide written informed consent * Subject is incarcerated at the time of the study * Subject previously participated in this study
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reference range intervals for measurement of Clot Time (CT) parameter | Baseline, determined from a single blood draw | Reference range intervals determined in this study will serve as the reference range for CT on the QStat Cartridge when it is commercially available. |
| Reference range intervals for measurement of Clot Stiffness (CS) parameter | Baseline, determined from a single blood draw | Reference range intervals determined in this study will serve as the reference range for CS on the QStat Cartridge when it is commercially available. |
| Reference range intervals for measurement of Fibrinogen Contribution to Clot Stiffness (FCS) parameter | Baseline, determined from a single blood draw | Reference range intervals determined in this study will serve as the reference range for FCS on the QStat Cartridge when it is commercially available. |
| Reference range intervals for measurement of Platelet Contribution to Clot Stiffness (PCS) parameter | Baseline, determined from a single blood draw | Reference range intervals determined in this study will serve as the reference range for PCS on the QStat Cartridge when it is commercially available. |
| Reference range intervals for measurement of Clot Stability to Lysis (CSL) parameter | Baseline, determined from a single blood draw | Reference range intervals determined in this study will serve as the reference range for CSL on the QStat Cartridge when it is commercially available. |
Countries
United States
Outcome results
None listed